phase readout
saveNCT07400523: Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy
RECRUITINGupdated 46m ago
community read0 votes
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: PHASE3. Conditions: Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that